Clinical Trial Update: The Multi Center, Randomized, Double-blind, Positive Controlled Study of Bicyclol in the Treatment of Acute DILI [Phase 2]

View source ↗

Summary

Phase 2 randomized trial evaluating bicyclol for acute drug-induced liver injury has completed enrollment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Drug-induced Acute Liver Injury

Drugs mentioned

• Bicyclol (bicyclol)

Snippet

Sponsor: Drug Induced Liver Disease Study Group | Conditions: Drug-Induced Acute Liver Injury | Phase 2 | Status: COMPLETED